Journal of Biological Chemistry · 2006 · 40 citations · 49 references
Life SciencesBiochemistryCell BiologyEndocytosisLipid BiochemistryMembrane TraffickingCholesterol MetabolismLipid DisordersLipid MetabolismLipid TransportLipoprotein MetabolismApolipoprotein A-i MetabolismAtp-binding Cassette TransportersCellular Cholesterol TraffickingCholesterol AccumulationCholesterol EffluxCholesterol Trafficking DefectsLysosomal Cholesterol TransportNiemann-pick Disease Type C
Impaired cell cholesterol trafficking in Niemann-Pick type C (NPC) disease results in the first known instance of impaired regulation of the ATP-binding cassette transporter A1 (ABCA1), a lipid transporter mediating the rate-limiting step in high density lipoprotein (HDL) formation, as a cause of low plasma HDL-cholesterol in humans. We show here that treatment of human NPC1-/- fibroblasts with the liver X receptor (LXR) agonist TO-901317 increases ABCA1 expression and activity in human NPC1-/- fibroblasts, as indicated by near normalization of efflux of radiolabeled phosphatidylcholine and a marked increase in efflux of cholesterol mass to apoA-I. LXR agonist treatment prior to and during apoA-I incubation resulted in reduction in filipin staining of unesterified cholesterol in late endosomes/lysosomes, as well as cholesterol mass, in NPC1-/- cells. HDL species in human NPC disease plasma showed the same pattern of diminished large, cholesterol-rich α-1 HDL particles as seen in isolated heterozygous ABCA1 deficiency. Incubating NPC1-/- fibroblasts with the LXR agonist normalized the pattern of HDL particle formation by these cells. ABCG1, another LXR target gene involved in cholesterol efflux to HDL, also showed diminished expression in NPC1-/- fibroblasts and increased expression upon LXR agonist treatment. These results suggest that NPC1 mutations can be largely bypassed and that NPC1 protein function is non-essential for the trafficking and removal of cellular cholesterol if the down-stream defects in ABCA1 and ABCG1 regulation in NPC disease cells are corrected using an LXR agonist. Impaired cell cholesterol trafficking in Niemann-Pick type C (NPC) disease results in the first known instance of impaired regulation of the ATP-binding cassette transporter A1 (ABCA1), a lipid transporter mediating the rate-limiting step in high density lipoprotein (HDL) formation, as a cause of low plasma HDL-cholesterol in humans. We show here that treatment of human NPC1-/- fibroblasts with the liver X receptor (LXR) agonist TO-901317 increases ABCA1 expression and activity in human NPC1-/- fibroblasts, as indicated by near normalization of efflux of radiolabeled phosphatidylcholine and a marked increase in efflux of cholesterol mass to apoA-I. LXR agonist treatment prior to and during apoA-I incubation resulted in reduction in filipin staining of unesterified cholesterol in late endosomes/lysosomes, as well as cholesterol mass, in NPC1-/- cells. HDL species in human NPC disease plasma showed the same pattern of diminished large, cholesterol-rich α-1 HDL particles as seen in isolated heterozygous ABCA1 deficiency. Incubating NPC1-/- fibroblasts with the LXR agonist normalized the pattern of HDL particle formation by these cells. ABCG1, another LXR target gene involved in cholesterol efflux to HDL, also showed diminished expression in NPC1-/- fibroblasts and increased expression upon LXR agonist treatment. These results suggest that NPC1 mutations can be largely bypassed and that NPC1 protein function is non-essential for the trafficking and removal of cellular cholesterol if the down-stream defects in ABCA1 and ABCG1 regulation in NPC disease cells are corrected using an LXR agonist. High density lipoprotein cholesterol (HDL-C) 5The abbreviations used are: HDL, high density lipoprotein; apo, apolipoprotein; ABCA1, ATP-binding cassette transporter A1; CE, cholesteryl ester; CETP, cholesteryl ester transfer protein; DMEM, Dulbecco's modified Eagle's medium; FAFA, fatty acid-free albumin; LCAT, lecithin:cholesterol acyltransferase; LXR, liver X receptor; LDL, low density lipoprotein; NPC, Niemann-Pick type C; PBS; phosphate-buffered saline; PLTP, phospholipid transfer protein; UC, unesterified cholesterol; TBST, Tris-buffered saline containing 1% Tween 20. levels in plasma correlate strongly with protection against atherosclerotic vascular disease (1Rubins H.B. Robins S.J. Iwane M.K. Boden W.E. Elam M.B. Fye C.L. Gordon D.J. Schaefer E.J. Schectman G. Wittes J.T. Am. J. Cardiol. 1993; 71: 45-52Abstract Full Text PDF PubMed Scopus (89) Google Scholar), believed to be due mainly to the removal of cholesterol by HDL from cells in the artery wall and other tissues (2Yokoyama S. Biochim. Biophys. Acta. 2000; 1529: 231-244Crossref PubMed Scopus (119) Google Scholar). Mobilization of cell phospholipids and cholesterol to lipid-poor HDL apolipoproteins (apos) by the actions of the membrane transporter ATP-binding cassette transporter A1 (ABCA1) is the rate-limiting step in HDL particle formation (3Oram J.F. Heinecke J.W. Physiol. Rev. 2005; 85: 1343-1372Crossref PubMed Scopus (432) Google Scholar). Delivery of additional cell cholesterol to HDL occurs by ABCA1-independent mechanisms, possibly facilitated by the actions of other membrane transporters including ABCG1 (4Klucken J. Buchler C. Orso E. Kaminski W.E. Porsch-Ozcurumez M. Liebisch G. Kapinsky M. Diederich W. Drobnik W. Dean M. Allikmets R. Schmitz G. Proc. Natl. Acad. Sci. U. S. A. 2000; 97: 817-822Crossref PubMed Scopus (479) Google Scholar, 5Wang N. Lan D. Chen W. Matsuura F. Tall A.R. Proc. Natl. Acad. Sci. U. S. A. 2004; 101: 9774-9779Crossref PubMed Scopus (899) Google Scholar), ABCG4 (5Wang N. Lan D. Chen W. Matsuura F. Tall A.R. Proc. Natl. Acad. Sci. U. S. A. 2004; 101: 9774-9779Crossref PubMed Scopus (899) Google Scholar), or scavenger receptor class B type I (6Ji Y. Jian B. Wang N. Sun Y. Moya M.L. Phillips M.C. Rothblat G.H. Swaney J.B. Tall A.R. J. Biol. Chem. 1997; 272: 20982-20985Abstract Full Text Full Text PDF PubMed Scopus (637) Google Scholar). Further maturation of HDL occurs through the esterification of cholesterol on the particle surface by lecithin:cholesterol acyltransferase (LCAT) (7Fielding C.J. Fielding P.E. J. Lipid Res. 1995; 36: 211-228Abstract Full Text PDF PubMed Google Scholar), and transfer to the HDL pool of surface components of triglyceride-rich lipoproteins during their hydrolysis (8Havel R.J. Kane J.P. Scriver C.R. Beaudet A.L. Sly W.S. Valle D. The Metabolic and Molecular Bases of Inherited Disease. McGraw Hill Inc., New York2001: 2705-2716Google Scholar). The presence of approximately half-normal HDL-C levels in individuals heterozygous for ABCA1 mutations (9Assmann G. Von Eckardstein A. Brewer H.B. Scriver C.R. Beaudet A.L. Sly W.S. Valle D. The Metabolic and Molecular Bases of Inherited Disease. McGraw Hill Inc., New York2001: 2937-2980Google Scholar, 10Asztalos Schaefer E.J. Full Text Full Text PDF PubMed Scopus Google Scholar), ABCA1 activity is a of HDL-C levels in and that efflux and in HDL maturation for an in ABCA1 activity to increase HDL-C Niemann-Pick type C (NPC) disease is a by of unesterified cholesterol and other in late and and impaired cholesterol trafficking to other cell M.C. E.J. Scriver C.R. Beaudet A.L. Sly W.S. Valle D. The Metabolic Molecular Bases of Inherited Disease. New York2001: Scholar, W.S. M. J. Lipid Res. Full Text Full Text PDF PubMed Google Scholar). with impaired regulation of cholesterol and esterification and low density lipoprotein receptor activity in S. Proc. Natl. Acad. Sci. U. S. A. PubMed Scopus Google Scholar, J. Biol. Chem. Full Text PDF PubMed Google Scholar), that and expression of ABCA1 is diminished in fibroblasts from a with NPC to impaired of B. W.S. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar). We also that of NPC disease low plasma HDL-C B. W.S. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar). These that impaired regulation of ABCA1 to low plasma HDL-C is an of NPC NPC disease the first known of HDL formation and low HDL-C as a of impaired ABCA1 The of impaired ABCA1 regulation and HDL formation to the and of cholesterol and other in tissues including the liver in NPC disease is by and J. Biol. Chem. Full Text PDF PubMed Google that of the the of cholesterol esterification in human NPC disease fibroblasts, of cholesterol in these cells. These results the the of cholesterol from the late to the and Y. J. M. J. Biol. Chem. 2000; Full Text Full Text PDF PubMed Scopus Google showed that of including to human NPC disease fibroblasts cholesterol and increased as by the pool of cholesterol for esterification in cell These also that reduction of cholesterol in the presence of plasma membrane in a of cholesterol to the plasma membrane in the presence of the NPC1 Y. J. M. J. Biol. Chem. 2000; Full Text Full Text PDF PubMed Scopus Google Scholar). A. N. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google impaired in human NPC1 and disease fibroblasts, and of cholesterol mass and filipin staining of late in human NPC disease cells with in the presence of or these results suggest that of gene regulation cholesterol trafficking in the presence of mutations in the NPC1 or of ABCA1 expression is of the receptor liver X receptor ABCA1 to cell cholesterol by HDL Y. Wang N. Tall A.R. J. Biol. Chem. 2000; Full Text Full Text PDF PubMed Scopus Google Scholar, J. Full Text Full Text PDF PubMed Scopus Google Scholar). the of the agonist of LXR, the regulation of ABCA1 and lipid efflux to apoA-I and HDL particle formation in human NPC disease fibroblasts, in the of of on cholesterol and receptor results of ABCA1 expression and near normalization of lipid as well as of ABCG1 expression and HDL particle formation, in the presence of NPC1 with LXR agonist treatment. These results suggest LXR or possibly the trafficking and of cholesterol and other in NPC LXR agonist fatty acid-free and filipin from and from Dulbecco's modified Eagle's from and from and and from of and and from plasma of by J.P. J. Lipid Res. Full Text PDF PubMed Google Scholar). The protein of HDL by HDL, and apoA-I using the of S. S. A. J. PubMed Scopus Google for of using as W. R. J. 1993; PubMed Scopus Google Scholar), to a activity of of for of HDL particle species from a NPC disease for the of NPC1 and and human fibroblasts from the NPC1 human fibroblasts containing NPC1 mutations and from the cells or and NPC1-/- cells or and to in containing and 1% indicated cells with containing cholesterol for as B. W.S. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar). with or cholesterol for the to in containing to receptor expression prior to cholesterol of and in with cholesterol by incubation with containing protein for cholesterol cells with containing and an additional to hydrolysis of and of cholesterol in in the or presence of TO-901317 from a in with prior to or of efflux cells in with cholesterol for and with in TO-901317 during the B. W.S. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar). with prior to of efflux and and cells for in containing apoA-I in the or presence of efflux and cells with and with lipid for to cell in cells with or the for of radiolabeled phosphatidylcholine J. M. G.H. J. Biol. Chem. Full Text PDF PubMed Google Scholar). cellular by and for as J.F. Heinecke J.W. PubMed Scopus Google Scholar). of cell using as A.L. R.J. J. Biol. Chem. Full Text PDF PubMed Google Scholar). in with LDL, and for in the or presence of TO-901317 with apoA-I TO-901317 for and cells and cells by from or cell by C to the and in the presence of as the with and by with a and to a The from to and to the for used as the The in with a of of The in the and and the D. S. G. R. R. J. Lipid Res. 2004; Full Text Full Text PDF PubMed Scopus Google Scholar). of by their with and of mass in on the on and with as The cells in the or presence of TO-901317 during the and during a or incubation with apoA-I. with in for with and with filipin as A. N. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar), with in with for with and with filipin in for with and filipin by on a with a of in with of and by for The in of containing containing in and The by for and by for cellular membrane in the by for and in containing and to of membrane by and to using a ABCA1 from and a with and as by of HDL from the NPC and and on by for particles by and NPC1 human fibroblasts, in for to cells and the by and on and used the same or HDL particles to the of Schaefer E.J. Full Text Full Text PDF PubMed Scopus Google as HDL particles in of to the of and Fielding Fielding C.J. PubMed Scopus Google that in the increased from for to for to increase the of the HDL in the first by in for in the with a for in High protein on the the with and the of protein by a incubation in Tris-buffered saline containing 1% Tween and particles by the with apoA-I in containing 1% for and with The activity of the for in of containing 1% and of by of in Biochim. Biophys. Acta. 1993; PubMed Scopus Google Scholar). from isolated from fibroblasts as B. W.S. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar). of by for by for ABCG1 for and for for a of with a of ABCG4 using with a of of used for LCAT, and phospholipid transfer protein cholesteryl ester transfer protein and an of the of the on a with and in with B. W.S. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar). The used ABCG1, human CETP, LCAT, PLTP, are as using the ABCA1 in NPC1-/- by LXR low and levels of ABCA1 and protein in human NPC1-/- fibroblasts B. W.S. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar), with impaired and gene regulation in LXR can ABCA1 expression in NPC disease NPC1-/- fibroblasts in the presence of the LXR agonist TO-901317 A. S. Wang S. M. D.J. B. 2000; PubMed Scopus Google or the and B. W.S. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar), ABCA1 protein levels low in NPC1-/- cells to in or with with fibroblasts of TO-901317 or of the to NPC1-/- cells increased ABCA1 protein to levels to seen in or LXR cells. seen in ABCA1 levels by the of the on ABCA1 is the the same for and showed results cell for that are to of other in NPC1-/- cells. These results of for cell and that ABCA1 expression is increased by LXR in NPC1-/- cells. of and in NPC1-/- with LXR impaired efflux of plasma and cholesterol as well as the phospholipids phosphatidylcholine and to apoA-I from human NPC1-/- fibroblasts B. W.S. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar). increased ABCA1 expression in to LXR agonist lipid efflux to the of from and from to apoA-I from cells in the presence or of in the presence of TO-901317 for prior to and during the efflux to apoA-I. in and as of cell protein to apoA-I from NPC1-/- cells with cells in the of LXR agonist. The presence of LXR agonist efflux of from NPC1-/- cells to levels from and to of levels seen from apoA-I LXR cells ABCA1 function is to or near levels in NPC1-/- cells by of the LXR and that ABCA1 can phosphatidylcholine to apoA-I in the presence of NPC1 of LXR agonist to NPC1-/- cells the efflux of to apoA-I to levels to in to of levels in LXR cells of to apoA-I from NPC1-/- cells be to be from cells in the presence of LXR due to of by the pool of unesterified cholesterol in NPC1-/- with cells S. J. Biol. Chem. Full Text PDF PubMed Google Scholar). LXR NPC1-/- of cholesterol efflux from cell in cholesterol mass in the and cellular of type and NPC disease fibroblasts with apoA-I in the or presence of LXR agonist. cholesterol mass in the of NPC1-/- cells in the of cells mass efflux to apoA-I from NPC1-/- cells from cells of cholesterol efflux to the from NPC1-/- efflux of cholesterol mass to the of and NPC1-/- The results in of efflux of cholesterol mass to containing cholesterol mass in the of NPC1-/- cholesterol mass in the of apoA-I NPC1-/- with S. Proc. Natl. Acad. Sci. U. S. A. PubMed Scopus Google Scholar, S. J. Biol. Chem. Full Text PDF PubMed Google Scholar), NPC1-/- fibroblasts with and with showed cholesteryl ester mass and unesterified cholesterol mass with treatment mass in cells by of LXR with ABCA1 cholesterol that be by acyltransferase J.F. J. 1995; PubMed Scopus Google Scholar). seen in NPC1-/- cells with apoA-I of LXR agonist in the apoA-I incubation resulted in of mass in NPC1-/- cells. with apoA-I for to mass in or NPC1-/- cells of LXR agonist to the apoA-I incubation resulted in a in mass in and a in NPC1-/- cells and These results suggest of ABCA1 expression also the of apoA-I to NPC1-/- cells of cholesterol mass, in the presence of NPC1 of NPC disease cells is of of cholesterol in late as by staining with the unesterified filipin in the same pattern as or staining for these B. J. PubMed Scopus Google Scholar, S.J. C.L. A. M. N. J. S. Brewer H.B. J. Biol. Chem. 2004; Full Text Full Text PDF PubMed Scopus Google Scholar). staining of and NPC1-/- fibroblasts to upon incubation with apoA-I in the or presence of LXR agonist. and of NPC1-/- fibroblasts with apoA-I resulted in in the filipin staining with cells with of LXR agonist during the apoA-I resulted in filipin staining an that These results are with the in mass in these cells and suggest of LXR in NPC1-/- cells is of late cholesterol in the of NPC1 protein HDL in NPC and NPC the presence of low plasma HDL-C levels in of NPC B. W.S. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar). to correlate with in cholesterol mass efflux to apoA-I from NPC disease fibroblasts, of HDL particles in the plasma of an NPC disease and in of NPC1-/- cells. HDL in the plasma of a NPC disease showed a near of α-1 and and a in and HDL particles with HDL species seen in an and and a These in HDL species in NPC disease plasma are to for disease also showed levels of and HDL particles Schaefer E.J. Full Text Full Text PDF PubMed Scopus Google Scholar). These results suggest that ABCA1 activity in NPC as in heterozygous is for the of in NPC The of these cholesterol-rich a in plasma HDL particles Fielding C.J. PubMed Scopus Google Scholar, E.J. Brewer H.B. N. J. PubMed Scopus Google Scholar), the diminished plasma HDL-C in NPC of HDL particles in the of NPC1-/- cells with apoA-I for showed a near of and with apoA-I of human fibroblasts of LXR agonist during the apoA-I incubation resulted in a marked increase in particle formation in cell and the HDL species by NPC1-/- cells to a pattern These results of of HDL particle formation by an LXR agonist in the presence of NPC1 Impaired ABCG1 in NPC to expression of ABCA1, the impaired cholesterol trafficking and in NPC disease be to the expression of E. J. PubMed Scopus Google Scholar). ABCA1 is believed to be the of the of apoA-I in HDL particle formation (3Oram J.F. Heinecke J.W. Physiol. Rev. 2005; 85: 1343-1372Crossref PubMed Scopus (432) Google Scholar), of cholesterol to HDL particles occurs in through the actions of another ABCG1, expression is also LXR (4Klucken J. Buchler C. Orso E. Kaminski W.E. Porsch-Ozcurumez M. Liebisch G. Kapinsky M. Diederich W. Drobnik W. Dean M. Allikmets R. Schmitz G. Proc. Natl. Acad. Sci. U. S. A. 2000; 97: 817-822Crossref PubMed Scopus (479) Google Scholar, 5Wang N. Lan D. Chen W. Matsuura F. Tall A.R. Proc. Natl. Acad. Sci. U. S. A. 2004; 101: 9774-9779Crossref PubMed Scopus (899) Google Scholar, A. J. N. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar). The of ABCG1 expression in human NPC disease ABCA1 B. W.S. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar), levels of ABCG1 in human NPC1-/- fibroblasts with cells ABCG1 to a in cell upon incubation with LXR agonist. These results suggest the of HDL particle formation in LXR NPC1-/- fibroblasts be in by increased ABCG1 in to increased ABCA1 LXR to show impaired expression in NPC disease and involved in cholesterol efflux and of HDL particle ABCG4 (5Wang N. Lan D. Chen W. Matsuura F. Tall A.R. Proc. Natl. Acad. Sci. U. S. A. 2004; 101: 9774-9779Crossref PubMed Scopus (899) Google Scholar, S. A. S. B. G. G. Biophys. Res. PubMed Scopus Google Scholar), D.J. Proc. Natl. Acad. Sci. U. S. A. PubMed Scopus Google Scholar), Y. Tall A.R. J. 2000; PubMed Scopus Google Scholar), and G. R.J. Y. Y. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar). ABCG4 in or or LXR agonist. is to formation of HDL particles through particle N. M. C. M. J. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar), and is G. R.J. Y. Y. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar). We to diminished in NPC1-/- fibroblasts, an increase in expression incubation with TO-901317 in NPC1-/- or the maturation of HDL particles by cholesterol on the HDL particle to be LXR ester levels low in the efflux from or NPC1-/- fibroblasts activity is to the increase in HDL particle seen in LXR NPC1-/- We to in or or NPC1-/- The that an agonist of the receptor LXR can the impaired regulation and activity of ABCA1 in human NPC disease cells. The increased ABCA1 protein in NPC1-/- cells is as indicated by near normalization of phosphatidylcholine and increased cholesterol efflux to apoA-I. ABCA1 is believed to to the plasma membrane the pool of in late W. Sun Y. C. A. A.R. Tall A.R. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar), that be to the for esterification by of acyltransferase pool by the of apoA-I to cholesteryl ester mass in LXR NPC1-/- as seen in cells in the or presence of LXR agonist. LXR agonist treatment resulted in a marked in unesterified cholesterol mass, as well as late cholesterol by filipin in NPC1-/- cells. expression and activity of ABCA1 by LXR agonist TO-901317 treatment in cell and tissues A. S. Wang S. M. D.J. B. 2000; PubMed Scopus Google Scholar, J. B. D.J. 2000; PubMed Scopus Google Scholar, PubMed Scopus Google Scholar). the show the of increased expression of ABCA1 by agonist to increase the of and late cholesterol in the presence of NPC1 ABCA1 in NPC1-/- fibroblasts be cholesterol mainly from the plasma with of late cholesterol by an to plasma membrane cholesterol to or in ABCA1 be cholesterol from the late by a also of ABCA1 for of cholesterol from the late a of cholesterol efflux to apoA-I S.J. C.L. A. M. N. J. S. Brewer H.B. J. Biol. Chem. 2004; Full Text Full Text PDF PubMed Scopus Google Scholar, Y. Proc. Natl. Acad. Sci. U. S. A. PubMed Scopus Google Scholar, W. Wang N. Tall A.R. J. Biol. Chem. 2005; Full Text Full Text PDF PubMed Scopus Google Scholar). of ABCA1 is cholesterol from the late or results of ABCA1 can largely NPC1 mutations and increase cholesterol trafficking and removal from NPC disease cells. The near normalization of phospholipid efflux to apoA-I from LXR NPC1-/- fibroblasts NPC1 function is for of ABCA1 the plasma membrane or in The of LXR agonist treatment to cholesterol efflux to normalization of ABCA1 The first is that incubation of NPC1-/- fibroblasts with LXR agonist and apoA-I to a of as indicated by a in filipin staining be the The is that increased ABCA1 can largely cholesterol from late in the presence of NPC1 and that NPC1 function is for a of cholesterol removal from of also be the results suggest increased expression of ABCA1 is to the of the of NPC1 on cholesterol trafficking for efflux to and as that NPC1 function is for The increase in cholesterol in NPC1-/- cells LXR agonist and apoA-I treatment be due in to increased cholesterol in these cells. showed in cholesterol in to the LXR agonist in and NPC1-/- cells J. Biol. Chem. Full Text PDF PubMed Google Scholar). the levels in NPC1-/- cells is to the for to in an of cholesterol by the NPC1-/- cells. We also near of α-1 and HDL particles in the plasma of a NPC disease heterozygous for ABCA1 mutations show the same pattern of of species Schaefer E.J. Full Text Full Text PDF PubMed Scopus Google Scholar), and approximately half-normal plasma HDL-C levels (9Assmann G. Von Eckardstein A. Brewer H.B. Scriver C.R. Beaudet A.L. Sly W.S. Valle D. The Metabolic and Molecular Bases of Inherited Disease. McGraw Hill Inc., New York2001: 2937-2980Google Scholar). These results suggest that the reduction in HDL-C and of in NPC plasma are due mainly to ABCA1 expression and activity in with LXR agonist corrected the pattern of of and in NPC1-/- to the pattern of HDL species seen in cell These results that NPC1 protein in NPC1-/- cells can be bypassed to the cholesterol trafficking for HDL particle The also impaired expression of ABCG1 in human NPC disease cells. ABCG1 is an additional LXR gene involved in cholesterol of ABCG1, with ABCA1 and other LXR including be to be in or tissues in NPC due to the of unesterified cholesterol in late endosomes/lysosomes, and the in of A. N. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar). LXR agonist treatment also corrected ABCG1 expression in human NPC1-/- fibroblasts that the of the of cholesterol and HDL particle formation by LXR agonist in NPC1-/- cells increased ABCA1 these results suggest ABCG1 also a in ABCG1 to of cell cholesterol to HDL to by a that HDL particle to the cell surface (5Wang N. Lan D. Chen W. Matsuura F. Tall A.R. Proc. Natl. Acad. Sci. U. S. A. 2004; 101: 9774-9779Crossref PubMed Scopus (899) Google Scholar). of ABCG1 cholesterol to cell surface the cholesterol is to removal by HDL J.F. J. Biol. Chem. 2005; Full Text Full Text PDF PubMed Scopus Google Scholar). LXR agonist TO-901317 treatment of results in of ABCG1 from to the plasma with a increase in cholesterol efflux to HDL N. M. Matsuura F. F. Tall A.R. Biol. PubMed Scopus Google Scholar). The of increased cholesterol efflux to apoA-I cholesterol efflux to HDL in the trafficking and removal of cholesterol from NPC disease cells The of expression of LXR and ABCG4 in human fibroblasts a for these in the of lipid and HDL formation in an of these in the impaired cholesterol in other NPC disease including the the results of in human NPC disease cells can be using cells from of NPC disease is show in plasma HDL-C C. Proc. Natl. Acad. Sci. U. S. A. PubMed Scopus Google Scholar, J. J.F. S. 36: PubMed Google Scholar), of human NPC to B. W.S. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar). is seen the of low ABCA1 expression in fibroblasts S.J. A. Proc. Natl. Acad. Sci. U. S. A. PubMed Google Scholar), as seen in of human NPC disease fibroblasts B. W.S. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google and the These suggest in HDL in with the an to of NPC using the same LXR agonist as used here increased ABCA1 and ABCG1 in the of type with the agonist in PubMed Scopus Google Scholar), and increased ABCA1 and ABCG1 in type cells in PubMed Scopus Google Scholar, B. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar), of the agonist on cholesterol efflux from these cells to apoA-I PubMed Scopus Google Scholar, B. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar). seen in ABCA1 and ABCG1 levels in the of type and the increase in ABCA1 and ABCG1 expression with TO-901317 treatment to the protection against cell and seen in with the S.J. A. Proc. Natl. Acad. Sci. U. S. A. PubMed Google Scholar). are to well expression of ABCA1 and ABCG1 in fibroblasts with expression of these transporters in the of human with NPC and of these transporters in the to increased in these the of an agonist of the receptor LXR to ABCA1 expression and activity and largely phospholipid and cholesterol efflux to as well as HDL particle formation, in the presence of NPC1 ABCG1 expression to be low in NPC1-/- and also corrected with LXR agonist treatment. of LXR agonist during apoA-I late cholesterol staining by as well as unesterified cholesterol mass in NPC1-/- cells. These results suggest the NPC1 protein is non-essential for the trafficking and removal of cell cholesterol if the defects in ABCA1 and ABCG1 expression by NPC1 can be corrected E. J. PubMed Scopus Google Scholar). of ABCA1 ABCG1 expression be to a in human NPC or NPC1 another in to of cholesterol from late endosomes/lysosomes, are of We and for with the of from NPC disease and
49
Role of LXRs in control of lipogenesis
Joshua R. Schultz, Hua Tu, Alvin Luk et al. · Genes & Development · 2000 · 1.7K citations · Full text
Molecular physiology of reverse cholesterol transport.
C J Fielding, P E Fielding · Journal of Lipid Research · 1995 · 1.4K citations · Full text
Regulation of Absorption and ABC1-Mediated Efflux of Cholesterol by RXR Heterodimers
Joyce J. Repa, S D Turley, Jean Marc Lobaccaro et al. · Science · 2000 · 1.3K citations